Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms.

MLA

Waseem, Najeff, et al. “Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 60, no. 7, July 2019, pp. 882–91. EBSCOhost, https://doi.org/10.2967/jnumed.118.217851.

APA

Waseem, N., Aparici, C. M., & Kunz, P. L. (2019). Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, 60(7), 882–891. https://doi.org/10.2967/jnumed.118.217851

Chicago

Waseem, Najeff, Carina Mari Aparici, and Pamela L Kunz. 2019. “Evaluating the Role of Theranostics in Grade 3 Neuroendocrine Neoplasms.” Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 60 (7): 882–91. doi:10.2967/jnumed.118.217851.